Haematology S&E Director — Early-Stage Partnerships

BioSpace

Waltham (MA)

Hybrid

USD 180,000 - 240,000

Full time

5 days ago

Be an early applicant

Application generator

An application made for this job — a tailored resume and cover letter that speak straight to the posting.

Get past ATS filters

Job summary

CSL Behring is seeking a Director of Search & Evaluation to lead strategic sourcing and evaluation of external innovation in Haematology. Embedded within the Therapeutic Area Leadership Team (TALT), the role shapes early asset strategy from preclinical through Phase 1 and drives partnering and transactions in collaboration with Business Development.

The position is hybrid-based onsite (3 days a week) at one of our R&D hub sites: Zurich, Maidenhead, Waltham, or King of Prussia.

Qualifications

Significant tenure in biopharma with external innovation, search & evaluation, or business development.
Advanced degree required (PhD, MD, or equivalent).
Must have deep scientific expertise in Haematology.
Proven track record of leading due diligence and closing early-stage deals.
Strong network within biotech, academia, and pharma BD organizations.

Responsibilities

Serve as the senior Early S&E leader within the TALT, influencing therapeutic strategy and ensuring external innovation priorities are integrated into portfolio planning.
Lead proactive sourcing and scouting efforts for preclinical and Phase 1 assets, building a robust pipeline of opportunities aligned with TA strategy.
Co-lead internal meetings focused on evaluating and prioritizing New Product Opportunities within Haematology, advancing assets for due diligence and deal negotiations.
Develop and execute early partnering strategies, including onboarding approaches and competitive positioning for priority assets.
Drive cross-functional due diligence for each opportunity, coordinating scientific, clinical, regulatory, and commercial assessments to inform governance decisions.
Transaction execution: partner with BD and Regional Ecosystem Leads to advance opportunities through negotiation and deal close.
Represent the TA externally, leading sourcing activities at conferences and cultivating relationships with biotech, academia, and investment communities.